Literature DB >> 19652903

Membranous glomerulonephritis in a patient with ankylosing spondylitis: a rare association.

Ruchika Gupta1, Alok Sharma, Raman Arora, Amit K Dinda, Ankur Gupta, Suresh C Tiwari.   

Abstract

Ankylosing spondylitis is a chronic inflammatory disease of the vertebral joints and soft tissues. Renal involvement, apart from amyloidosis, is rare in this disorder. Of the various glomerulonephritides reported in association with ankylosing spondylitis, IgA nephropathy is the most common. Membranous glomerulonephritis occurs very rarely in patients with ankylosing spondylitis, and only four such cases have been reported in the available English literature. Due to the rarity of this association, membranous glomerulonephritis may not initially be considered in patients with ankylosing spondylitis and proteinuria. We report the case of a 29-year-old man with ankylosing spondylitis who presented with pedal edema and was detected to have nephrotic syndrome. A percutaneous renal biopsy showed features of membranous glomerulonephritis with capillary wall granular deposits of IgG and C3 on immunofluorescence and subepithelial immune complex deposits on electron microscopy. No other secondary cause of membranous glomerulopathy was found on extensive investigations. Membranous glomerulonephritis is extremely rare in association with ankylosing spondylitis, the present case being the fifth such report. The exact relationship of these two entities (etiological or coincidental) still needs to be elucidated. The occurrence of this rare association needs to be recognized and differentiated from other more common causes of renal involvement in ankylosing spondylitis.

Entities:  

Mesh:

Year:  2009        PMID: 19652903     DOI: 10.1007/s10157-009-0217-z

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  15 in total

1.  Membranous glomerulonephritis complicating ankylosing spondylitis.

Authors:  G Efstratiadis; G Tsiaousis; M Leontsini; L Gionanlis; A Papagianni; D Memmos
Journal:  Clin Nephrol       Date:  2006-07       Impact factor: 0.975

2.  Renal involvement in ankylosing spondylitis (Bechterew's disease)

Authors:  A V Nabokov; M A Shabunin; A V Smirnov
Journal:  Nephrol Dial Transplant       Date:  1996-06       Impact factor: 5.992

3.  Mesangial IgM nephropathy in a patient with HLA-B27 spondylarthropathy.

Authors:  K Steinsson; P Hirszel; A Weinstein
Journal:  Arthritis Rheum       Date:  1983-08

4.  Membranous nephropathy in ankylosing spondylitis.

Authors:  A Botey; A Torras; L Revert
Journal:  Nephron       Date:  1981       Impact factor: 2.847

5.  Circulating immune complexes in patients with ankylosing spondylitis.

Authors:  G S Panayi; J Slaney; B D Williams
Journal:  Ann Rheum Dis       Date:  1980-10       Impact factor: 19.103

6.  Coexistence of HLA-B27 ankylosing spondylitis and DR4 seropositive nodular rheumatoid arthritis in patient with membranous nephropathy.

Authors:  J P Lemmer; W R Irby
Journal:  J Rheumatol       Date:  1981 Jul-Aug       Impact factor: 4.666

7.  Glomerulonephritis in ankylosing spondylitis.

Authors:  K H Shu; J D Lian; Y F Yang; Y S Lu; J Y Wang; J L Lan; G Chou
Journal:  Clin Nephrol       Date:  1986-04       Impact factor: 0.975

8.  Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy.

Authors:  Hiroshi Ohtani; Hideki Wakui; Atsushi Komatsuda; Shin Okuyama; Rie Masai; Nobuki Maki; Akihiro Kigawa; Ken-ichi Sawada; Hirokazu Imai
Journal:  Nephrol Dial Transplant       Date:  2004-03       Impact factor: 5.992

9.  IgG subclass deposits in glomeruli of lupus and nonlupus membranous nephropathies.

Authors:  M Haas
Journal:  Am J Kidney Dis       Date:  1994-03       Impact factor: 8.860

10.  Renal abnormalities in ankylosing spondylitis.

Authors:  D W Jones; M A Mansell; C T Samuell; D A Isenberg
Journal:  Br J Rheumatol       Date:  1987-10
View more
  6 in total

Review 1.  Pulmonary, renal and neurological comorbidities in patients with ankylosing spondylitis; implications for clinical practice.

Authors:  Cecilia Mercieca; Irene E van der Horst-Bruinsma; Andrew A Borg
Journal:  Curr Rheumatol Rep       Date:  2014-08       Impact factor: 4.592

2.  A case report on nephrotic syndrome associated with ankylosing spondylitis effectively treated with infliximab.

Authors:  Xin Feng; Yao Li; Wei Gao
Journal:  Int J Clin Exp Med       Date:  2014-09-15

3.  A spontaneous model of spondyloarthropathies that develops bone loss and pathological bone formation: A process regulated by IL27RA-/- and mutant-p53.

Authors:  Denada Dibra; Xueqing Xia; Mihai Gagea; Guillermina Lozano; Shulin Li
Journal:  PLoS One       Date:  2018-03-01       Impact factor: 3.240

4.  Membranous nephropathy in a patient with ankylosing spondylitis: A case report.

Authors:  Ruiying Chen; Fang Li; Qionghong Xie; Jun Xue; Lingyun Lai; Shaojun Liu; Liyin Zhang; Chuanming Hao
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.889

5.  Secondary Membranous Nephropathy. A Narrative Review.

Authors:  Gabriella Moroni; Claudio Ponticelli
Journal:  Front Med (Lausanne)       Date:  2020-12-03

6.  Membranous nephropathy and thymoma in a patient with ankylosing spondylitis: A case report.

Authors:  Lirong Lin; Lei Zhao; Bengang Huo; Luquan Zheng; Rongjie Yu; Weibing Li; Jurong Yang
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.